This pricing term sheet supplements the information set forth under “Description of the Series E Preferred Stock” in the preliminary prospectus supplement, dated April 27, 2021 (the “Preliminary Prospectus Supplement”) to the prospectus dated February 22, 2019.
| | |
Issuer: | | Regions Financial Corporation |
| |
Security: | | Depositary shares (the “Depositary Shares”) each representing a 1/40th interest in a share of 4.45% Non-Cumulative Perpetual Preferred Stock, Series E, of the Issuer (the “Preferred Stock”) |
| |
Expected Security Ratings (Moody’s/S&P/Fitch):* | | Ba1 / BB+ / BB (Stable/Stable/Stable) |
| |
Size: | | $400,000,000 / 16,000,000 Depositary Shares |
| |
Over-allotment Option: | | No over-allotment option applies to this offering. |
| |
Liquidation Preference: | | $25 per Depositary Share (equivalent to $1,000 per share of Preferred Stock) |
| |
Term: | | Perpetual |
| |
Dividend Rate (Non-Cumulative): | | From the date of issuance at a rate of 4.45% per annum, payable quarterly in arrears |
| |
Dividend Payment Dates: | | Quarterly in arrears on March 15, June 15, September 15 and December 15 of each year, commencing on September 15, 2021 |
| |
Day Count: | | 30/360 |
| |
Trade Date: | | April 27, 2021 |
| |
Settlement Date: | | May 4, 2021 (T+5)** |
| |
Optional Redemption: | | The Issuer may redeem the Preferred Stock, at its option, at a price equal to $1,000 per share (equivalent to $25 per Depositary Share), plus any declared and unpaid dividends (without regard to any undeclared dividends) to but excluding the redemption date, (i) in whole or in part, from time to time, on any dividend payment date on or after June 15, 2026 or (ii) in whole, but not in part, at any time following a regulatory capital treatment event (as defined in the Preliminary Prospectus Supplement). |
| |
Listing: | | Application will be made to list the Depositary Shares on the New York Stock Exchange (the “NYSE”) under the symbol “RFPrE.” If approved for listing, trading of the Depositary Shares on the NYSE is expected to commence within the 30-day period after the original issuance date of the Depositary Shares |
| |
Public Offering Price: | | $25 per Depositary Share |
| |
Underwriting Discounts and Commissions: | | $9,461,000, reflecting 5,840,000 Depositary Shares sold to institutional investors, for which the underwriters received an underwriting discount of $0.2500 per Depositary Share, and 10,160,000 Depositary Shares sold to retail investors, for which the underwriters received an underwriting discount of $0.7875 per Depositary Share |
| |
Net Proceeds to Issuer (after underwriting discounts and commissions, before offering expenses): | | $390,539,000 |